Work

Editorial: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions

Year: 2025
Type: editorial
Abstract: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions
Language: English
Open Access status: gold
Estimated APC paid: $1,779
OpenAlex ID: W4416614198
Cites: 8
Cited by: 2
Related to: